Skip to content

Effects of the Personalized Self-management Program on Metabolic Syndrome for Prostate Cancer Patients with Androgen Derivation Therapy

Effects of the Personalized Self-management Program on Metabolic Syndrome for Prostate Cancer Patients with Androgen Derivation Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006560
Enrollment
48
Registered
2021-09-09
Start date
2021-03-24
Completion date
Unknown
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Experimental group: combined intervention including exercise and diet for 4 weeks, monitoring for 8 weeks Control group: usual care

Sponsors

Yonsei University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Patients who have received ADT therapy for at least 6 months. (2) Those with at least one of the five metabolic syndrome factors in the abnormal range. (3) A person who is fully aware of the purpose and contents of the research and voluntarily participated in the research. (4) A person who can understand Korean and can communicate without cognitive impairment.

Exclusion criteria

Exclusion criteria: (1) Those who have been diagnosed with other cancer except for prostate cancer and are being treated. (2) Those who have undergone surgery or chemotherapy within the last 3 months. (3) Those who answered “yes” to one or more of the Physical Activity Readiness Questionnaires (PAR-Q). (4) Those with cardiovascular diseases such as unstable angina pectoris, uncontrolled blood pressure, and myocardial infarction. (5) Those who have serious complications such as musculoskeletal and nervous system diseases. (6) Those who participate in other intervention programs or change medication to control blood pressure, cholesterol, and blood sugar within the last 3 months from the initiation time of participation in the program. (7) Participants who cannot use data due to missing data such as primary variables. (8) Those who have difficulty in independent activities or daily life.

Design outcomes

Primary

MeasureTime frame
HRQoL related to disease (EPIC-SF26

Secondary

MeasureTime frame
Five components of Metabolic syndrome;Body composition;CHS index

Countries

Korea, Republic of

Contacts

Public ContactKyoungjin Lee

Yonsei University

milenius1004 @gmail.com+82-2-2228-3368

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026